Integrin alpha V (ITGAV) (C-Term) Peptid
Kurzübersicht für Integrin alpha V (ITGAV) (C-Term) Peptid (ABIN5511060)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- C-Term
-
Sequenz
- ILAVLAGLLL LAVLVFVMYR MGFFKRVRPP QEEQEREQLQ PHENGEGNSE
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- ITGAV Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CD51 (ITGAV) (Integrin alpha V (ITGAV))
-
Hintergrund
-
The product of this gene belongs to the integrin alpha chain family. Integrins are heterodimeric integral membrane proteins composed of an alpha subunit and a beta subunit that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha V subunit. This subunit associates with beta 1, beta 3, beta 5, beta 6 and beta 8 subunits. The heterodimer consisting of alpha V and beta 3 subunits is also known as the vitronectin receptor. This integrin may regulate angiogenesis and cancer progression. Alternative splicing results in multiple transcript variants. Note that the integrin alpha 5 and integrin alpha V subunits are encoded by distinct genes.
Alias Symbols: CD51, MSK8, VNRA, VTNR
Protein Size: 1048 -
Gen-ID
- 3685
-
NCBI Accession
- NM_001144999, NP_001138471
-
UniProt
- P06756
Target
-